Journal of Molecular and Cellular Cardiology
Volume 50, Issue 1 , Pages 43-49 , January 2011

Histidine-rich calcium binding protein: The new regulator of sarcoplasmic reticulum calcium cycling

  • Demetrios A. Arvanitis

      Affiliations

    • Molecular Biology Division, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    • ,
  • Elizabeth Vafiadaki

      Affiliations

    • Molecular Biology Division, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    • ,
  • Despina Sanoudou

      Affiliations

    • Molecular Biology Division, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    • Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Greece
    • ,
  • Evangelia G. Kranias

      Affiliations

    • Molecular Biology Division, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    • Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA
    • Corresponding Author InformationCorresponding author. Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0575, USA. Tel.: +1 513 558 2377; fax: +1 513 558 0646.

Received 3 March 2010 ,Revised 6 August 2010 ,Accepted 22 August 2010.

References 

  1. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res. 1998;37:279–289
  2. Schmidt AG, Edes I, Kranias EG. Phospholamban: a promising therapeutic target in heart failure?. Cardiovasc Drugs Ther. 2001;15:387–396
  3. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med. 2009;15:380–383
  4. Hofmann SL, Brown MS, Lee E, Pathak RK, Anderson RG, Goldstein JL. Purification of a sarcoplasmic reticulum protein that binds Ca2+ and plasma lipoproteins. J Biol Chem. 1989;264:8260–8270
  5. Arvanitis DA, Vafiadaki E, Fan GC, Mitton BA, Gregory KN, Del Monte F, et al. Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. Am J Physiol Heart Circ Physiol. 2007;293:H1581–H1589
  6. Gregory KN, Ginsburg KS, Bodi I, Hahn H, Marreez YM, Song Q, et al. Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function. J Mol Cell Cardiol. 2006;40:653–665
  7. Kim E, Shin DW, Hong CS, Jeong D, Kim DH, Park WJ. Increased Ca2+ storage capacity in the sarcoplasmic reticulum by overexpression of HRC (histidine-rich Ca2+ binding protein). Biochem Biophys Res Commun. 2003;300:192–196
  8. Lee HG, Kang H, Kim DH, Park WJ. Interaction of HRC (histidine-rich Ca(2+)-binding protein) and triadin in the lumen of sarcoplasmic reticulum. J Biol Chem. 2001;276:39533–39538
  9. Sacchetto R, Damiani E, Turcato F, Nori A, Margreth A. Ca(2+)-dependent interaction of triadin with histidine-rich Ca(2+)-binding protein carboxyl-terminal region. Biochem Biophys Res Commun. 2001;289:1125–1134
  10. Campbell KP, MacLennan DH, Jorgensen AO. Staining of the Ca2+-binding proteins, calsequestrin, calmodulin, troponin C, and S-100, with the cationic carbocyanine dye "Stains-all". J Biol Chem. 1983;258:11267–11273
  11. Damiani E, Margreth A. Subcellular fractionation to junctional sarcoplasmic reticulum and biochemical characterization of 170kDa Ca(2+)- and low-density-lipoprotein-binding protein in rabbit skeletal muscle. Biochem J. 1991;277(Pt 3):825–832
  12. Damiani E, Tarugi P, Calandra S, Margreth A. Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. Dev Biol. 1992;153:102–114
  13. Orr I, Shoshan-Barmatz V. Modulation of the skeletal muscle ryanodine receptor by endogenous phosphorylation of 160/150-kDa proteins of the sarcoplasmic reticulum. Biochim Biophys Acta. 1996;1283:80–88
  14. Picello E, Damiani E, Margreth A. Low-affinity Ca(2+)-binding sites versus Zn(2+)-binding sites in histidine-rich Ca(2+)-binding protein of skeletal muscle sarcoplasmic reticulum. Biochem Biophys Res Commun. 1992;186:659–667
  15. Shoshan-Barmatz V, Orr I, Weil S, Meyer H, Varsanyi M, Heilmeyer LM. The identification of the phosphorylated 150/160-kDa proteins of sarcoplasmic reticulum, their kinase and their association with the ryanodine receptor. Biochim Biophys Acta. 1996;1283:89–100
  16. Sacchetto R, Turcato F, Damiani E, Margreth A. Interaction of triadin with histidine-rich Ca(2+)-binding protein at the triadic junction in skeletal muscle fibers. J Muscle Res Cell Motil. 1999;20:403–415
  17. Hojlund K, Bowen BP, Hwang H, Flynn CR, Madireddy L, Geetha T, et al. In vivo phosphoproteome of human skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS. J Proteome Res. 2009;8:4954–4965
  18. Bousette N, Kislinger T, Fong V, Isserlin R, Hewel JA, Emil A, et al. Large-scale characterization and analysis of the murine cardiac proteome. J Proteome Res. 2009;8:1887–1901
  19. Zhou X, Fan GC, Ren X, Waggoner JR, Gregory KN, Chen G, et al. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury. Cardiovasc Res. 2007;75:487–497
  20. Fan GC, Gregory KN, Zhao W, Park WJ, Kranias EG. Regulation of myocardial function by histidine-rich, calcium-binding protein. Am J Physiol Heart Circ Physiol. 2004;287:H1705–H1711
  21. Arvanitis DA, Sanoudou D, Kolokathis F, Vafiadaki E, Papalouka V, Kontrogianni-Konstantopoulos A, et al. The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. Eur Heart J. 2008;29:2514–2525
  22. Asimaki A, Syrris P, Wichter T, Matthias P, Saffitz JE, McKenna WJ. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2007;81:964–973
  23. Hofmann SL, Topham M, Hsieh CL, Francke U. cDNA and genomic cloning of HRC, a human sarcoplasmic reticulum protein, and localization of the gene to human chromosome 19 and mouse chromosome 7. Genomics. 1991;9:656–669
  24. Brown SD, Chartier F, Johnson K, Cavanna JS. Mapping the Hrc gene to proximal mouse chromosome 7: delineation of a conserved linkage group with human 19q. Genomics. 1993;18:459–461
  25. Raeymaekers L, Verbist J, Wuytack F, Plessers L, Casteels R. Expression of Ca2+ binding proteins of the sarcoplasmic reticulum of striated muscle in the endoplasmic reticulum of pig smooth muscles. Cell Calcium. 1993;14:581–589
  26. Ridgeway AG, Petropoulos H, Siu A, Ball JK, Skerjanc IS. Cloning, tissue distribution, subcellular localization and overexpression of murine histidine-rich Ca2+ binding protein. FEBS Lett. 1999;456:399–402
  27. Zarain-Herzberg A, MacLennan DH, Periasamy M. Characterization of rabbit cardiac sarco(endo)plasmic reticulum Ca2(+)-ATPase gene. J Biol Chem. 1990;265:4670–4677
  28. Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kangawa K, Minamino N, et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 1989;339:439–445
  29. Ellis SB, Williams ME, Ways NR, Brenner R, Sharp AH, Leung AT, et al. Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel. Science. 1988;241:1661–1664
  30. Korczak B, Zarain-Herzberg A, Brandl CJ, Ingles CJ, Green NM, MacLennan DH. Structure of the rabbit fast-twitch skeletal muscle Ca2+-ATPase gene. J Biol Chem. 1988;263:4813–4819
  31. Zarain-Herzberg A, Fliegel L, MacLennan DH. Structure of the rabbit fast-twitch skeletal muscle calsequestrin gene. J Biol Chem. 1988;263:4807–4812
  32. Anderson JP, Dodou E, Heidt AB, De Val SJ, Jaehnig EJ, Greene SB, et al. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol Cell Biol. 2004;24:3757–3768
  33. Guinamard R, Chatelier A, Demion M, Potreau D, Patri S, Rahmati M, et al. Functional characterization of a Ca(2+)-activated non-selective cation channel in human atrial cardiomyocytes. J Physiol. 2004;558:75–83
  34. Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest. 2009;119:2737–2744
  35. Beranger F, Mejean C, Moniot B, Berta P, Vandromme M. Muscle differentiation is antagonized by SOX15, a new member of the SOX protein family. J Biol Chem. 2000;275:16103–16109
  36. Maruyama M, Ichisaka T, Nakagawa M, Yamanaka S. Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells. J Biol Chem. 2005;280:24371–24379
  37. Lee HJ, Goring W, Ochs M, Muhlfeld C, Steding G, Paprotta I, et al. Sox15 is required for skeletal muscle regeneration. Mol Cell Biol. 2004;24:8428–8436
  38. Hong S, Kim TW, Choi I, Woo JM, Oh J, Park WJ, et al. Complementary DNA cloning, genomic characterization and expression analysis of a mammalian gene encoding histidine-rich calcium binding protein. Biochim Biophys Acta. 2005;1727:188–196
  39. Wang S, Trumble WR, Liao H, Wesson CR, Dunker AK, Kang CH. Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol. 1998;5:476–483
  40. Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem. 1997;272:23389–23397
  41. Nayler WG, Anderson JE. Effects of Zinc on Cardiac Muscle Contraction. Am J Physiol. 1965;209:17–21
  42. Suk JY, Kim YS, Park WJ. HRC (histidine-rich Ca2+ binding protein) resides in the lumen of sarcoplasmic reticulum as a multimer. Biochem Biophys Res Commun. 1999;263:667–671
  43. Shannon TR, Guo T, Bers DM. Ca2+ scraps: local depletions of free [Ca2+] in cardiac sarcoplasmic reticulum during contractions leave substantial Ca2+ reserve. Circ Res. 2003;93:40–45
  44. Gyorke I, Hester N, Jones LR, Gyorke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J. 2004;86:2121–2128
  45. Guo W, Campbell K. Association of Triadin with the Ryanodine Receptor and Calsequestrin in the Lumen of the Sarcoplasmic Reticulum. J Biol Chem. 1995;270:9027–9030
  46. Toyoshima C, Mizutani T. Crystal structure of the calcium pump with a bound ATP analogue. Nature. 2004;430:529–535
  47. Toyoshima C, Nomura H, Tsuda T. Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues. Nature. 2004;432:361–368
  48. Dally S, Bredoux R, Corvazier E, Andersen JP, Clausen JD, Dode L, et al. Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+-ATPase 2 isoform (SERCA2c). Biochem J. 2006;395:249–258
  49. Kimura T, Nakamori M, Lueck JD, Pouliquin P, Aoike F, Fujimura H, et al. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet. 2005;14:2189–2200
  50. Lytton J, MacLennan DH. Molecular cloning of cDNAs from human kidney coding for two alternatively spliced products of the cardiac Ca2+-ATPase gene. J Biol Chem. 1988;263:15024–15031
  51. Zarain-Herzberg A, Alvarez-Fernandez G. Sarco(endo)plasmic reticulum Ca2+-ATPase-2 gene: structure and transcriptional regulation of the human gene. ScientificWorldJournal. 2002;2:1469–1483
  52. Protonotarios N, Tsatsopoulou A, Patsourakos P, Alexopoulos D, Gezerlis P, Simitsis S, et al. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J. 1986;56:321–326
  53. Rubenstein A, Merriam J, Klymkowsky MW. Localizing the adhesive and signaling functions of plakoglobin. Dev Genet. 1997;20:91–102
  54. Green KJ, Gaudry CA. Are desmosomes more than tethers for intermediate filaments?. Nat Rev Mol Cell Biol. 2000;1:208–216
  55. Emanuelsson O, Brunak S, von Heijne G, Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc. 2007;2:953–971
  56. Terentyev D, Viatchenko-Karpinski S, Gyorke I, Volpe P, Williams SC, Gyorke S. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci USA. 2003;100:11759–11764
  57. Viatchenko-Karpinski S, Terentyev D, Gyorke I, Terentyeva R, Volpe P, Priori SG, et al. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res. 2004;94:471–477
  58. Lahat H, Pras E, Eldar M. A missense mutation in CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Ann Med. 2004;36(Suppl 1):87–91
  59. Eldar M, Pras E, Lahat H. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Cold Spring Harb Symp Quant Biol. 2002;67:333–337
  60. Eldar M, Pras E, Lahat H. A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia. Trends Cardiovasc Med. 2003;13:148–151
  61. Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet. 2001;69:1378–1384
  62. Song L, Alcalai R, Arad M, Wolf CM, Toka O, Conner DA, et al. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2007;117:1814–1823
  63. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200
  64. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001;103:485–490
  65. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10:189–194
  66. Sato Y, Ferguson DG, Sako H, Dorn GW, Kadambi VJ, Yatani A, et al. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem. 1998;273:28470–28477
  67. Ji Y, Lalli MJ, Babu GJ, Xu Y, Kirkpatrick DL, Liu LH, et al. Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function. J Biol Chem. 2000;275:38073–38080
  68. Periasamy M, Reed TD, Liu LH, Ji Y, Loukianov E, Paul RJ, et al. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem. 1999;274:2556–2562
  69. Dash R, Frank KF, Carr AN, Moravec CS, Kranias EG. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell Cardiol. 2001;33:1345–1353
  70. Jaehnig EJ, Heidt AB, Greene SB, Cornelissen I, Black BL. Increased susceptibility to isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice lacking the histidine-rich calcium-binding protein. Mol Cell Biol. 2006;26:9315–9326
  71. Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation. 1990;81:III21–III32
  72. Gupta RC, Mishra S, Rastogi S, Wang M, Rousso B, Mika Y, et al. Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals. Clin Transl Sci. 2009;2:211–215
  73. van den Broek FA, Bakker R, den Bieman M, Fielmich-Bouwman AX, Lemmens AG, van Lith HA, et al. Genetic analysis of dystrophic cardiac calcification in DBA/2 mice. Biochem Biophys Res Commun. 1998;253:204–208
  74. de Meeus A, Stephan E, Debrus S, Jean MK, Loiselet J, Weissenbach J, et al. An isolated cardiac conduction disease maps to chromosome 19q. Circ Res. 1995;77:735–740
  75. Brink PA, Ferreira A, Moolman JC, Weymar HW, van der Merwe PL, Corfield VA. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation. 1995;91:1633–1640

PII: S0022-2828(10)00324-X

doi: 10.1016/j.yjmcc.2010.08.021

Journal of Molecular and Cellular Cardiology
Volume 50, Issue 1 , Pages 43-49 , January 2011

Article Tools

* Image Usage & Resolution